LncRNAs as key players in the MYC pathways

Taewan Kim

Genome Instability & Disease ›› 2021, Vol. 2 ›› Issue (1) : 24 -38.

PDF
Genome Instability & Disease ›› 2021, Vol. 2 ›› Issue (1) : 24 -38. DOI: 10.1007/s42764-021-00032-3
Review Article

LncRNAs as key players in the MYC pathways

Author information +
History +
PDF

Abstract

Recent advancements in genomic and computational technologies have identified numerous untranslated noncoding transcripts including long noncoding RNAs (lncRNAs) in the human genome. Subsequently, the abundance and functional diversity of lncRNAs have been characterized in cellular and pathological pathways of various diseases and cancer. The transcription factor MYC is one of the most pivotal oncogenes, and the oncogenic pathways of MYC have been thought to be competently elucidated. However, recent studies implicating lncRNAs in the MYC pathways show that our research endeavors and knowledge to this day do not thoroughly elaborate the MYC pathways in cancer. It has been shown in recent studies that lncRNAs employ novel mechanisms to tune MYC activity and orchestrate MYC pathways. Furthermore, a number of lncRNAs that have not been dissected have been profiled and identified in the oncogenic MYC pathways. Thus, the research focusing on lncRNAs provides novel biological knowledge of the MYC pathways and will eventually lead to new potential biomarkers and therapeutic targets in MYC-driven cancers. This review discusses the various functional mechanisms of MYC-associated lncRNAs in MYC activity and MYC pathways.

Cite this article

Download citation ▾
Taewan Kim. LncRNAs as key players in the MYC pathways. Genome Instability & Disease, 2021, 2(1): 24-38 DOI:10.1007/s42764-021-00032-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

Funding

National Natural Science Foundation of China(82073120)

AI Summary AI Mindmap
PDF

144

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/